Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Dow Inc
DOW
|
+$477M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$413M |
| 3 |
Microsoft
MSFT
|
+$413M |
| 4 |
Amazon
AMZN
|
+$354M |
| 5 |
Corteva
CTVA
|
+$316M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$330M |
| 2 |
Cisco
CSCO
|
+$140M |
| 3 |
Altria Group
MO
|
+$122M |
| 4 |
TJX Companies
TJX
|
+$113M |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$109M |
Sector Composition
| 1 | Technology | 18.33% |
| 2 | Financials | 15.46% |
| 3 | Healthcare | 13.81% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Delek US
DK
$1.92B
| $40.5M | 0.01% |
1,000,482
-51,729
| -5% | -$2.1M |
|
|
QTS
1002
DELISTED
QTS REALTY TRUST, INC.
QTS
| $40.5M | 0.01% |
876,129
+73,914
| +9% | +$3.41M |
|
1003
United Therapeutics
UTHR
$18.3B
| $40.4M | 0.01% |
517,318
-56,290
| -10% | -$4.39M |
|
1004
MSC Industrial Direct
MSM
$5.12B
| $40.3M | 0.01% |
542,861
+34,149
| +7% | +$2.54M |
|
|
CLGX
1005
DELISTED
Corelogic, Inc.
CLGX
| $40.3M | 0.01% |
963,200
+35,285
| +4% | +$1.48M |
|
1006
Skywest
SKYW
$4.35B
| $40.2M | 0.01% |
662,333
+33,627
| +5% | +$2.04M |
|
|
ENV
1007
DELISTED
ENVESTNET, INC.
ENV
| $40.1M | 0.01% |
586,849
+52,571
| +10% | +$3.59M |
|
|
PGRE
1008
Paramount Group
PGRE
$1.6B
| $40.1M | 0.01% |
2,859,798
+145,058
| +5% | +$2.03M |
|
1009
Alkermes
ALKS
$4.6B
| $40.1M | 0.01% |
1,778,041
+158,433
| +10% | +$3.57M |
|
1010
Globus Medical
GMED
$7.98B
| $40M | 0.01% |
946,425
+76,109
| +9% | +$3.22M |
|
1011
Iovance Biotherapeutics
IOVA
$858M
| $40M | 0.01% |
1,632,556
+159,148
| +11% | +$3.9M |
|
1012
Wendy's
WEN
$1.89B
| $40M | 0.01% |
2,043,071
-2,061
| -0.1% | -$40.4K |
|
1013
Olin
OLN
$2.91B
| $40M | 0.01% |
1,824,525
+30,140
| +2% | +$660K |
|
1014
Darling Ingredients
DAR
$5.01B
| $39.9M | 0.01% |
2,005,013
+134,028
| +7% | +$2.67M |
|
|
NUVA
1015
DELISTED
NuVasive, Inc.
NUVA
| $39.9M | 0.01% |
680,981
+51,845
| +8% | +$3.03M |
|
1016
FIVE9
FIVN
$2.04B
| $39.8M | 0.01% |
776,235
+68,625
| +10% | +$3.52M |
|
1017
Home BancShares
HOMB
$5.76B
| $39.8M | 0.01% |
2,066,220
+74,867
| +4% | +$1.44M |
|
1018
Acadia Pharmaceuticals
ACAD
$4.19B
| $39.8M | 0.01% |
1,487,832
+66,169
| +5% | +$1.77M |
|
1019
WaFd
WAFD
$2.48B
| $39.7M | 0.01% |
1,137,727
+130,690
| +13% | +$4.56M |
|
1020
Amicus Therapeutics
FOLD
$2.43B
| $39.6M | 0.01% |
3,176,491
+452,284
| +17% | +$5.64M |
|
1021
Viavi Solutions
VIAV
$2.61B
| $39.6M | 0.01% |
2,978,820
+185,694
| +7% | +$2.47M |
|
1022
ASGN Inc
ASGN
$2.29B
| $39.6M | 0.01% |
652,701
+47,276
| +8% | +$2.86M |
|
1023
ScottsMiracle-Gro
SMG
$3.51B
| $39.5M | 0.01% |
401,485
+2,038
| +0.5% | +$201K |
|
|
DOC
1024
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $39.5M | 0.01% |
2,267,181
+181,107
| +9% | +$3.16M |
|
|
NEWR
1025
DELISTED
New Relic, Inc.
NEWR
| $39.4M | 0.01% |
455,368
-64,370
| -12% | -$5.57M |
|